AVANIA
LIVE

Serial Number

88600290

Owner

AVANIA INVESTMENTS BV

Attorney

Roberto Ledesma

First Use Date

Mar 2, 2020

Filing Date

Aug 30, 2019

Add to watchlist:

No watchlists yet
View on USPTO

AVANIA Trademark

Serial Number: 88600290 • Registration: 6071106

AVANIA is a trademark filed by AVANIA INVESTMENTS BV on August 30, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

AVANIA INVESTMENTS BV (2 trademarks)

BILTHOVEN 3723MB , NL

Entity Type: 26

Factory CRO Investments BV (2 trademarks)

Bld. 54
Bilthoven 3723MB , NL

Entity Type: 99

EAGLE BIDCO B.V.

PROFESSOR BRONKHORSTLAAN 10
BILTHOVEN 3723 MB , NL

Entity Type: 26

Trademark Details

Filing Date

August 30, 2019

Registration Date

June 2, 2020

First Use Anywhere

March 2, 2020

First Use in Commerce

March 2, 2020

Published for Opposition

January 21, 2020

Goods & Services

Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, including orthopedic, cardiovascular, dermatology, and aesthetics; consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the Food and Drug Administration (FDA) by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management; Medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Business consulting services in the field of medical coding in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance and other third-party payers; Providing reimbursement services, namely, providing business advice and information relating to reimbursement strategies and support to companies involved in the healthcare field

Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields

Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports

Filing History

TEAS SECTION 8 & 15 RECEIVED
May 20, 2026 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 11, 2026 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 2, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 24, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 24, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 24, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 24, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 24, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 24, 2023 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 20, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 20, 2023 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 9, 2022 ASGN
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 30, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 29, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 3, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 3, 2020 AITU
USE AMENDMENT FILED
Mar 17, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 17, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 17, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2020 NONP
ASSIGNED TO LIE
Dec 13, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 10, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 10, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 10, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 10, 2019 CNEA
ASSIGNED TO EXAMINER
Dec 4, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2019 NWOS
NEW APPLICATION ENTERED
Sep 3, 2019 NWAP